---
category: news
title: "Alzheimer's Disease Researchers Release Free Memory Tracking App"
excerpt: "Leucadia Therapeutics Inc, a California HealthTech Company, is launching 8 Apps that help exercise memory and cognition, including"
publishedDateTime: 2021-07-09T19:30:00Z
originalUrl: "https://www.prnewswire.com/in/news-releases/alzheimer-s-disease-researchers-release-free-memory-tracking-app-829093138.html"
webUrl: "https://www.prnewswire.com/in/news-releases/alzheimer-s-disease-researchers-release-free-memory-tracking-app-829093138.html"
type: article
quality: 4
heat: -1
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - Computer Vision
  - AI

related:
  - title: "Alzheimer's Disease Researchers Release Free Memory Tracking App"
    excerpt: "Today, Leucadia Therapeutics Inc, a California HealthTech Company, is launching 8 Apps that help exercise memory and cognition, including a personalized memory tracker"
    publishedDateTime: 2021-07-09T10:00:00Z
    webUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_health/alzheimers-disease-researchers-release-free-memory-tracking-app/article_9684c7ea-dc94-5ebb-95f5-f8814e780430.html"
    type: article
    provider:
      name: WFMZ-TV
      domain: wfmz.com
    quality: 24
    images:
      - url: "https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/assets/v3/editorial/8/17/8173628b-8b64-568c-88c4-f087e50c8e1a/60e81eed3a56f.image.jpg?resize=1120%2C630"
        width: 1120
        height: 630
        isCached: true
  - title: "Facing intense criticism, FDA narrows use of Alzheimer’s drug to patients with early-stage disease"
    excerpt: "WASHINGTON — The Food and Drug Administration on Thursday limited the recommended use of a controversial new Alzheimer’s drug to patients with mild cognitive impairment or early dementia from ..."
    publishedDateTime: 2021-07-08T19:51:00Z
    webUrl: "https://www.seattletimes.com/nation-world/facing-intense-criticism-fda-narrows-use-of-alzheimers-drug-to-patients-with-early-stage-disease/"
    ampWebUrl: "https://www.seattletimes.com/nation-world/facing-intense-criticism-fda-narrows-use-of-alzheimers-drug-to-patients-with-early-stage-disease/?amp=1"
    cdnAmpWebUrl: "https://www-seattletimes-com.cdn.ampproject.org/c/s/www.seattletimes.com/nation-world/facing-intense-criticism-fda-narrows-use-of-alzheimers-drug-to-patients-with-early-stage-disease/?amp=1"
    type: article
    provider:
      name: Seattle Times
      domain: seattletimes.com
    quality: 10

secured: "k6MTTnKOMDwaMaGJQxIuDx4mrBoeEfB7W/YvNd/7Ylg1t06e8r4xJf8ZrpoDeBhmaXmuXeWQV72WiKrEmU3jTiLepmsOAeSZam6vyGJMtojUmwBXvHwalE9hYripm12YdxgH7Ef+3eQqEH/xuS0bRZXWr3RfEELwgQ8BckaLf5aMVfY1ZwcDwTIs9ol7NCUONrJEXMw1MdY0WfSS5INXq0oTuWxkTOkpPfwWkYFZ+aoinWXILolNTKi5Uy2+PFFjYlLrzgCQd051T3BJikfiW4tfWtm48cNWqO52zlizUkRvNpnKFl+ZAA1bGwwNCdY3eKLyofYFofzWjDAKp4cDFWk49sLAVXkonO5mruWrDzo=;c6KJ3EuAVg2sIMKdDgQ5/w=="
---

